// App-Quantinova.ai

11062 : Human equilibrative nucleoside transporter 1 as a predictor of efficacy to gemcitabine in angiosarcoma and leiomyosarcoma.

Researchers

Presenter

  • Bruno Vincenzi

Principal Investigators

  • Silvia Stacchiotti

  • Paola Collini

  • Francesco Pantano

  • Giuseppe Perrone

  • Michele Iuliani

  • Alfonso Baldi

  • Giuseppe Badalamenti

  • Roberta Sanfilippo

  • Daniele Santini

  • Andrea Onetti-Muda

  • Alessandro Gronchi

  • Paolo Giovanni Casali

  • Angelo Paolo Dei Tos

  • Giuseppe Tonini

Medical Centers

  • Department of Anatomical Pathology, Campus Bio-Medico University of Rome, Rome, Italy

  • Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

  • Department of Anatomical Pathology, Campus Bio-Medico University of Rome, Rome, Italy

  • Department of Environmental, Biological and Pharmaceutical Sciences and Technologies, Second University of Naples, Naples, Italy

  • Department of Oncology, Medical Oncology Division, University of Palermo, Palermo, Italy

  • Instituto Tumori Milano, Ucata (AG), Italy

  • Azienda ULSS 9 Treviso, Treviso, Italy

  • Policlinico Universitario Campus Bio-Medico, Roma, Italy

Locations

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Leiomyosarcoma

  • Angiosarcoma

Biomarkers

  • Human equilibrative nucleoside transporter 1

Drug/Treatment

  • Gemcitabine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved